oxamic acid has been researched along with Asthma, Bronchial in 12 studies
Oxamic Acid: Amino-substituted glyoxylic acid derivative.
oxamic acid : A dicarboxylic acid monoamide resulting from the formal condensation of one of the carboxy groups of oxalic acid with ammonia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The inhibition of immediate allergen-induced airflow obstruction by lodoxamide tromethamine (LT), a new drug with properties considered to be similar to those of sodium cromoglycate, was studied in twelve young asthmatic volunteers." | 9.05 | The effect of lodoxamide tromethamine on the immediate asthmatic response to allergen provocation. ( Bentley, S; Davies, RJ; Graham, VA; Ollier, S, 1982) |
| "Lodoxamide tromethamine, a new cromolyn-like drug, was studied to determine its effectiveness and duration of action in preventing antigen-induced bronchospasm in 15 subjects with clinically stable extrinsic asthma." | 9.05 | Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm. ( Deutsch, RI; Siegel, SC; Tashkin, DP; Ungerer, RG, 1981) |
| "The efficacy of lodoxamide tromethamine in the treatment of asthma was studied in a 16-week double-blind, placebo-controlled study of 68 perennial allergic subjects with asthma." | 9.05 | Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study. ( Clement, P; Fairfax, AJ; Holgate, ST; Mann, JS; Sheridan, AQ; Soryal, I, 1985) |
| "We monitored 14 asthmatic subjects (aged 18 to 60 years), with multiple 24-hour electrocardiogram (Holter) recordings, who were taking continuous sustained-release theophylline and beta-2-adrenergic therapy for control of their symptoms." | 7.67 | Lack of significant arrhythmogenicity from chronic theophylline and beta-2-adrenergic combination therapy in asthmatic subjects. ( Kelly, HW; Menendez, R; Voyles, W, 1985) |
| "The inhibition of immediate allergen-induced airflow obstruction by lodoxamide tromethamine (LT), a new drug with properties considered to be similar to those of sodium cromoglycate, was studied in twelve young asthmatic volunteers." | 5.05 | The effect of lodoxamide tromethamine on the immediate asthmatic response to allergen provocation. ( Bentley, S; Davies, RJ; Graham, VA; Ollier, S, 1982) |
| "Lodoxamide tromethamine, a new cromolyn-like drug, was studied to determine its effectiveness and duration of action in preventing antigen-induced bronchospasm in 15 subjects with clinically stable extrinsic asthma." | 5.05 | Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm. ( Deutsch, RI; Siegel, SC; Tashkin, DP; Ungerer, RG, 1981) |
| "The efficacy of lodoxamide tromethamine in the treatment of asthma was studied in a 16-week double-blind, placebo-controlled study of 68 perennial allergic subjects with asthma." | 5.05 | Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study. ( Clement, P; Fairfax, AJ; Holgate, ST; Mann, JS; Sheridan, AQ; Soryal, I, 1985) |
| "We monitored 14 asthmatic subjects (aged 18 to 60 years), with multiple 24-hour electrocardiogram (Holter) recordings, who were taking continuous sustained-release theophylline and beta-2-adrenergic therapy for control of their symptoms." | 3.67 | Lack of significant arrhythmogenicity from chronic theophylline and beta-2-adrenergic combination therapy in asthmatic subjects. ( Kelly, HW; Menendez, R; Voyles, W, 1985) |
| "A most active biologue of disodium cromoglycate (DSCG) available, lodoxamide tromethamine (LT), has been studied and characterized pharmacologically, in animal and human models of asthma." | 3.67 | The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma. ( Johnson, HG; Sheridan, AQ, 1986) |
| "Lodoxamide tromethamine (U-42,585E) is a new drug intended for prophylaxis of mast cell-mediated allergic disease." | 2.65 | Protective effect opf lodoxamide tromethamine on allergen inhalation challenge. ( Bewtra, AK; Bui, TC; Townley, RG; Watt, GD, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (91.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parrish, RW | 1 |
| Davies, BH | 1 |
| Case, RL | 1 |
| Rogers, PB | 1 |
| VanArsdel, PP | 1 |
| Altman, LC | 1 |
| Ollier, S | 1 |
| Graham, VA | 1 |
| Bentley, S | 1 |
| Davies, RJ | 1 |
| Ungerer, RG | 1 |
| Tashkin, DP | 1 |
| Siegel, SC | 3 |
| Deutsch, RI | 1 |
| Watt, GD | 1 |
| Bui, TC | 1 |
| Bewtra, AK | 1 |
| Townley, RG | 1 |
| Mawhinney, H | 2 |
| Spector, SL | 2 |
| Kinsman, RA | 1 |
| Rachelefsky, GS | 2 |
| Katz, RM | 2 |
| Rohr, AS | 2 |
| Lewis, AJ | 2 |
| Carlson, RP | 1 |
| Forster, TJ | 1 |
| Chang, J | 1 |
| Hand, JM | 1 |
| Undem, BJ | 1 |
| Buckner, CK | 1 |
| Tio, C | 1 |
| Sisenwine, SF | 1 |
| Daniel, WC | 1 |
| Kelly, HW | 1 |
| Menendez, R | 1 |
| Voyles, W | 1 |
| Johnson, HG | 1 |
| Sheridan, AQ | 2 |
| Kinsman, R | 1 |
| Mann, JS | 1 |
| Clement, P | 1 |
| Soryal, I | 1 |
| Fairfax, AJ | 1 |
| Holgate, ST | 1 |
1 review available for oxamic acid and Asthma, Bronchial
| Article | Year |
|---|---|
Do anti-allergic drugs or anticholinergic drugs have a role in the treatment of asthma?
Topics: Animals; Asthma; Bronchodilator Agents; Cromolyn Sodium; Humans; Mast Cells; Oxamic Acid; Parasympat | 1988 |
8 trials available for oxamic acid and Asthma, Bronchial
| Article | Year |
|---|---|
Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine.
Topics: Adult; Amino Acids; Asthma; Bronchial Provocation Tests; Clinical Trials as Topic; Double-Blind Meth | 1983 |
The protective effect of lodoxamide on antigen-induced bronchospasm. An orally active antiallergic drug.
Topics: Administration, Oral; Adult; Amino Acids; Asthma; Bronchial Provocation Tests; Bronchial Spasm; Clin | 1982 |
The effect of lodoxamide tromethamine on the immediate asthmatic response to allergen provocation.
Topics: Administration, Intranasal; Adult; Allergens; Amino Acids; Asthma; Bronchial Provocation Tests; Dose | 1982 |
Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm.
Topics: Adolescent; Adult; Amino Acids; Antigens; Asthma; Bronchial Spasm; Dose-Response Relationship, Immun | 1981 |
Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
Topics: Adolescent; Adult; Amino Acids; Analysis of Variance; Asthma; Bronchial Provocation Tests; Forced Ex | 1980 |
Compliance in clinical trials of two nonbronchodilator, antiasthma medications.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Asthma; Bronchi; Dose | 1991 |
Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials.
Topics: Adolescent; Adult; Aerosols; Aged; Amino Acids; Asthma; Clinical Trials as Topic; Female; Humans; Ma | 1986 |
Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
Topics: Adolescent; Adult; Aerosols; Amino Acids; Asthma; Chronic Disease; Double-Blind Method; Female; Huma | 1985 |
3 other studies available for oxamic acid and Asthma, Bronchial
| Article | Year |
|---|---|
The development of Wy-41,195, an orally effective antiallergic drug in animal models.
Topics: Administration, Oral; Amino Acids; Animals; Asthma; Disease Models, Animal; Dogs; Guinea Pigs; Hista | 1986 |
Lack of significant arrhythmogenicity from chronic theophylline and beta-2-adrenergic combination therapy in asthmatic subjects.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Arrhythmias, Cardiac; Asthma; Atrial Function; De | 1985 |
The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
Topics: Amino Acids; Animals; Asthma; Calcium; Cromolyn Sodium; Disease Models, Animal; Drug Evaluation; His | 1986 |